NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Schering-Plough Corporation 

2000 Galloping Hill Road

Kenilworth  New Jersey  07033  U.S.A.
Phone: 201-822-7000 Fax: 201-822-7447


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Big Pharma


Collaborations

Corvas International, Inc.  Oral anticoagulants in pre-clinical evaluations. Hepatitis C viral inhibitor in pre-clinical development.





 Company News
Schering-Plough Corporation (SGP)'s (JOBS) $10 Million Experiment With Digital Out-of-Home 11/12/2009 7:31:35 AM    More...
Merck & Co., Inc. (MRK) CEO Plans to Keep Schering-Plough Corporation (SGP) Headquarters 11/5/2009 7:38:55 AM    More...
Merck & Co., Inc. (MRK) (JOBS) and Schering-Plough Corporation (SGP) (JOBS) to Complete Merger Today; New Merck Will Begin Combined Operations Tomorrow 11/3/2009 10:53:15 AM    More...
Schering-Plough Corporation (SGP) Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 11/3/2009 8:07:10 AM    More...
Schering-Plough Corporation (SGP): Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies 11/2/2009 8:39:18 AM    More...
FDA Concerns Remain Over New Use for Schering-Plough Corporation (SGP) (JOBS) Drug, PegIntron 11/2/2009 7:23:10 AM    More...
Schering-Plough Corporation (SGP) (JOBS) Hep C Drug Promising in Phase II Study 11/2/2009 7:16:58 AM    More...
WuXi PharmaTech Co., Ltd. Receives 2009 Schering-Plough Corporation (SGP) Excellence Award 10/30/2009 10:39:40 AM    More...
U.S. Federal Trade Commission Ok's Merck & Co., Inc. (MRK) (JOBS)-Schering-Plough Corporation (SGP) (JOBS) Deal with Conditions 10/30/2009 6:55:27 AM    More...
Sanofi-Aventis (France) (SASY.PA) Release: Clinical Trial Logistics Strategies for Maximizing Efficiency, Safety and Regulatory Compliance Explored by Sanofi-Aventis (France) (SASY.PA), Pfizer Inc. (PFE), AstraZeneca PLC (AZN), Schering-Plough Corporation (SGP), FDA, DHS and Global BioPharm Solutions 10/29/2009 10:27:26 AM    More...
12345678910...